Study on the overall regulation of Xuebijing injection in treating COVID-19

SHI Xuan; WEI Juan; LIU Meiyun; JIN Xiaohong; ZHOU Huanping; ZHU Wanli; FENG Di; YANG Hao; LYU Xin

doi:10.16305/j.1007-1334.2020.04.098

您当前的位置：

首页 >

文章列表页 >

Study on the overall regulation of Xuebijing injection in treating COVID-19

更新时间：2022-08-31

- Study on the overall regulation of Xuebijing injection in treating COVID-19
- Shanghai Journal of Traditional Chinese Medicine Vol. 54, Issue 4, Pages: 46-52(2020)
- 作者机构：
  
  1. 同济大学附属上海市肺科医院麻醉科,上海,200433
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2020.04.098
  CLC：
扫描看全文
SHI Xuan, WEI Juan, LIU Meiyun, et al. Study on the overall regulation of Xuebijing injection in treating COVID-19. [J]. Shanghai Journal of Traditional Chinese Medicine 54(4):46-52(2020)
DOI：

SHI Xuan, WEI Juan, LIU Meiyun, et al. Study on the overall regulation of Xuebijing injection in treating COVID-19. [J]. Shanghai Journal of Traditional Chinese Medicine 54(4):46-52(2020) DOI： 10.16305/j.1007-1334.2020.04.098.

摘要

目的：探讨血必净注射液活性成分、靶标与新型冠状病毒肺炎之间存在的联系,为血必净注射液治疗新型冠状病毒肺炎以及后期的药物开发提供理论依据。方法：从“中药系统药理学数据库与分析平台”和已发表的文献中整合血必净注射液的有效成分和对应靶标,用Cytoscape软件构建网络并进行分析,使用DAVID和STRING数据库对得到的靶点进行通路富集分析。结果：①=1\*GB3通过数据库和文献检索,得到血必净注射液中的有效化合物成分共22个,共对应了504个潜在作用靶点。②=2\*GB3与新型冠状病毒的受体血管紧张素转化酶2(ACE2)共表达的靶点进行交集,得到70个交集蛋白,提示血必净注射液可能通过这70个蛋白对新型冠状病毒肺炎起治疗作用。③=3\*GB3靶点蛋白调控的通路主要集中在HIF-1信号通路、PI3K-Akt信号通路等一系列的通路中。结论：血必净注射液对于新型冠状病毒肺炎的治疗体现了中药多成分、多靶点的整体调控作用,可能通过对70个能与ACE2互作的蛋白,调控与疾病发生发展相关联的通路,缓解炎症反应,抑制病毒复制,从而起到抗病毒的作用。

Abstract

Objective:To explore the relationship between the active components and targets of Xuebijing injection and coronavirus disease 2019 (COVID-19), and to provide theoretical basis for Xuebijing injection in the treatment of COVID-19 and new drug development. MethodsThe active compounds of Xuebijing injection and corresponding targets of each compounds were obtained from the TCMSP database and published researches, and the network was constructed and analyzed by Cytoscape. GO and KEGG analyses were performed on the obtained targets by DAVID and STRING databases. Results:①=1\*GB3From the database and published researches, 22 compounds in Xuebijing injection were obtained, corresponding to 504 potential targets. ②Among them 70 proteins were intersected with targets co-expressed with angiotensin-converting enzyme 2 (ACE2), a receptor of the novel coronavirus, suggesting that Xuebijing injection may play a therapeutic role on COVID-19 through these 70 proteins. ③=3\*GB3These target proteins regulate a series of signaling pathways, such as HIF-1 signaling pathway and PI3K-Akt signaling pathway. Conclusion:Xuebijing injection reflected an overall regulation of multi-components and multi-targets of traditional Chinese medicine for the treatment of COVID-19. It may realize the anti-virus function by regulating the pathways related to the development of disease through 70 proteins that can interact with ACE2 to relieve inflammation and inhibit virus replication.

关键词

新型冠状病毒肺炎新型冠状病毒血必净注射液网络药理学血管紧张素转换酶2抗病毒多靶点整体调控

Keywords

COVID-19SARS-CoV-2Xuebijing injectionnetwork pharmacologyangiotensin-converting enzyme 2 (ACE2)anti-virusmulti-targetsoverall regulation

references

Views

1985

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploration of the characteristic and molecular mechanism of Chinese herbal medicines in the core formula for COVID-19’s cases based on data mining and network pharmacology

Experience of Yu Jian in treating children with SARS⁃CoV⁃2 infection——A proven critical case

Clinical study on intervention of Fuzheng Hejie Recipe in children with asymptomatic infection of SARS⁃CoV⁃2 Omicron variant

Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19

Investigation on traditional Chinese medicine syndrome characteristics in patients with chronic kidney disease and infected with Omicron variant of COVID⁃19

Related Author

No data

Related Institution

Department of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Respiratory Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Traditional Chinese Medicine， Fudan University of Children’s Hospital

Department of Intensive Care Unit， Fudan University of Children’s Hospital

⁰